The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
Approves CDC's Investment in NCMCL The (CCP) has approved the proposed investment by Central Depository…
Pakistan Meteorological Department Issues Seasonal Outlook for June The Pakistan Meteorological Department (PMD) has issued…
Reconciliation efforts between Khyber-Pakhtunkhwa's government and its dissident lawmakers have failed, as these members refuse…
US President Donald Trump will attend NATO meeting in Turkey this July. This comes after…
Strong winds and rainfall disrupted power supply across several regions served by Multan Electric Power…
European Union Announces Plans for Data Centre Energy Efficiency Standards The European Union has announced…
This website uses cookies.
